Trump’s $500 ACA Refunds: ‘We Shouldn’t Confuse a Check With a Healthcare Affordability Strategy’
Trump’s $500 ACA refunds offer immediate financial relief to some enrollees, but healthcare experts question whether they address the broader affordability challenges facing Americans.
North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent.
How a Cancer Diagnosis Shaped This VC’s Precision Health Thesis
After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and longevity fund that has backed 83 early-stage startups in three years.
The Missing Link in Surgical Safety: Integrating Patient Warming and Positioning
Historically, warming and positioning have been addressed independently because, in many surgical procedures, they do not significantly interfere with one another. However, that’s not the case in most robotic-assisted surgeries.
Novartis Gains a Way to Get Drugs Into the Brain, Buying Sironax Tech for $125M
Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The deal comes as Novartis weathers several pipeline setbacks, including trial failures for neuroscience drug candidates.